5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.40▼ | 1.40▼ | 1.40▼ | 1.43▼ | 1.27▲ |
MA10 | 1.41▼ | 1.41▼ | 1.41▼ | 1.33▲ | 1.15▲ |
MA20 | 1.41▼ | 1.42▼ | 1.44▼ | 1.28▲ | 1.05▲ |
MA50 | 1.43▼ | 1.41▼ | 1.34▲ | 1.11▲ | 0.99▲ |
MA100 | 1.38▼ | 1.29▲ | 1.27▲ | 1.03▲ | 1.14▲ |
MA200 | 1.28▲ | 1.29▲ | 1.23▲ | 1.01▲ | 5.72▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.009▼ | -0.015▼ | 0.011▲ | 0.048▲ |
RSI | 33.687▼ | 38.637▼ | 43.478▼ | 57.488▲ | 60.050▲ |
STOCH | 28.788 | 44.056 | 38.186 | 76.742 | 49.507 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -43.478 | -39.197 |
CCI | -136.111▼ | -183.575▼ | -185.654▼ | 65.048 | 102.643▲ |
MA | $HOTH Price Crossed Below MA(7) | Set Alert |
Wednesday, June 25, 2025 05:44 AM
Silo Pharma and Hoth Therapeutics announced a joint venture to develop a VA-co-developed obesity treatment utilizing GDNF technology.
|
Wednesday, June 18, 2025 11:34 AM
NEW YORK, June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained ...
|
Wednesday, June 18, 2025 11:34 AM
NEW YORK, June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/07/25 | 1.42 | 1.42 | 1.37 | 1.37 | 167,506 |
14/07/25 | 1.46 | 1.499 | 1.38 | 1.43 | 247,100 |
11/07/25 | 1.54 | 1.57 | 1.40 | 1.44 | 646,200 |
10/07/25 | 1.45 | 1.52 | 1.40 | 1.49 | 620,300 |
09/07/25 | 1.32 | 1.47 | 1.31 | 1.43 | 1,000,500 |
08/07/25 | 1.18 | 1.32 | 1.17 | 1.30 | 878,100 |
07/07/25 | 1.22 | 1.225 | 1.175 | 1.18 | 150,000 |
03/07/25 | 1.20 | 1.23 | 1.18 | 1.21 | 133,000 |
02/07/25 | 1.23 | 1.23 | 1.17 | 1.20 | 271,700 |
01/07/25 | 1.17 | 1.22 | 1.15 | 1.22 | 443,000 |
|
|
||||
|
|
||||
|
|